Blueberries Medical Corp
CNSX:BBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Blueberries Medical Corp
Accounts Receivables
Blueberries Medical Corp
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Blueberries Medical Corp
CNSX:BBM
|
Accounts Receivables
CA$81.7k
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Accounts Receivables
$2.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-1%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Accounts Receivables
CA$29m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
43%
|
|
|
Cronos Group Inc
TSX:CRON
|
Accounts Receivables
$34.1m
|
CAGR 3-Years
14%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Accounts Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Accounts Receivables
CA$127.8m
|
CAGR 3-Years
10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
46%
|
|
Blueberries Medical Corp
Glance View
Blueberries Medical Corp. engages in the production and distribution of psychoactive and non-psychoactive cannabis by-products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2014-04-09. The firm is engaged in the cultivation and development of medicinal cannabis and related products. The firm is specialized in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries also licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis.
See Also
What is Blueberries Medical Corp's Accounts Receivables?
Accounts Receivables
81.7k
CAD
Based on the financial report for Sep 30, 2025, Blueberries Medical Corp's Accounts Receivables amounts to 81.7k CAD.
What is Blueberries Medical Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 3Y
-40%
Over the last year, the Accounts Receivables growth was -36%. The average annual Accounts Receivables growth rates for Blueberries Medical Corp have been -40% over the past three years .
